REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 120 filers reported holding REVOLUTION MEDICINES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,785 | +20.4% | 46 | 0.0% | 0.00% | +200.0% |
| Q1 2024 | $1,483 | +12.4% | 46 | 0.0% | 0.00% | 0.0% |
| Q4 2023 | $1,319 | -100.0% | 46 | -100.0% | 0.00% | -100.0% |
| Q3 2023 | $34,064,143 | -50.6% | 1,230,641 | -52.2% | 22.62% | -15.5% |
| Q2 2023 | $68,940,635 | -30.5% | 2,577,220 | -43.7% | 26.76% | -25.4% |
| Q1 2023 | $99,156,014 | -9.1% | 4,577,840 | 0.0% | 35.85% | -1.2% |
| Q4 2022 | $109,044,149 | +20.8% | 4,577,840 | 0.0% | 36.30% | +81.7% |
| Q3 2022 | $90,275,000 | +5.4% | 4,577,840 | +4.2% | 19.98% | +9.6% |
| Q2 2022 | $85,660,000 | +0.3% | 4,395,050 | +31.3% | 18.23% | +15.2% |
| Q1 2022 | $85,388,000 | +1.4% | 3,347,245 | 0.0% | 15.83% | +38.2% |
| Q4 2021 | $84,250,000 | -8.5% | 3,347,245 | 0.0% | 11.46% | +9.4% |
| Q3 2021 | $92,083,000 | -13.3% | 3,347,245 | 0.0% | 10.48% | -30.3% |
| Q2 2021 | $106,242,000 | -35.3% | 3,347,245 | -6.5% | 15.04% | -4.4% |
| Q1 2021 | $164,262,000 | +15.9% | 3,580,252 | 0.0% | 15.74% | +22.4% |
| Q4 2020 | $141,742,000 | – | 3,580,252 | – | 12.86% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 1,909,317 | $75,590,000 | 52.65% |
| TRV GP III, LLC | 7,024,031 | $278,081,000 | 23.88% |
| Ponoi II Management, LLC | 685,011 | $27,120,000 | 19.76% |
| TRV GP IV, LLC | 1,419,900 | $56,214,000 | 18.03% |
| Ponoi Management, LLC | 685,011 | $27,120,000 | 15.52% |
| Column Group LLC | 3,580,252 | $141,742,000 | 12.86% |
| BVF INC/IL | 2,768,049 | $109,587,000 | 4.31% |
| Boxer Capital, LLC | 3,309,264 | $131,014,000 | 4.21% |
| Cormorant Asset Management, LP | 2,495,066 | $98,780,000 | 2.35% |
| Casdin Capital, LLC | 1,634,535 | $64,711,000 | 1.92% |